{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T04:04:56Z","timestamp":1750219496487,"version":"3.41.0"},"reference-count":45,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cell Biology International"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Despite some achievements in oxaliplatin\u2010based chemotherapy for the treatment of advanced hepatocellular carcinoma (HCC), the abnormal activation of DNA damage repair pathways in HCC cells remains a major problem, limiting the efficacy of oxaliplatin\u2010based chemotherapy. In a previous study, we found that endonuclease VIII\u2010like protein 3 (NEIL3) is expressed in a high proportion of patients with HCC and associated with an unfavourable prognosis. However, the role of NEIL3 in chemoresistance is still unclear. The aim of this study was to evaluate whether and how NEIL3 regulates oxaliplatin anti\u2010tumour efficacy. Gene expression after oxaliplatin treatment in HCC cell lines was assessed by real\u2010time quantitative PCR, western blot analysis and bioinformatics analysis. The effect of NEIL3 on regulating oxaliplatin efficacy was assessed using cell counting kit\u20108 assays, colony formation assays, flow cytometry and an in vivo nude mice study. Mechanistic insights into the sensitivity to oxaliplatin mediated by the inhibition of NEIL3 were obtained through immunofluorescence and RNA sequencing analyses. Our findings demonstrated that NEIL3 expression was markedly downregulated after oxaliplatin administration. NEIL3 knockdown impaired cell viability and colony formation and increased apoptosis in HCC cells exposed to oxaliplatin. In addition, NEIL3 inhibition reduced tumour progression and enhanced oxaliplatin efficacy in xenograft nude mice models. Furthermore, knocking down NEIL3 significantly increased the oxaliplatin\u2010mediated inhibition of the Fanconi anaemia pathway. Our results revealed that NEIL3 may be a promising therapeutic target for improving oxaliplatin efficacy in the treatment of HCC.<\/jats:p>","DOI":"10.1002\/cbin.70023","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T04:39:03Z","timestamp":1745383143000},"page":"824-835","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["NEIL3 Deficiency Enhances HCC Cell Sensitivity to Oxaliplatin by Inhibiting the Fanconi Anaemia Pathway"],"prefix":"10.1002","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6012-031X","authenticated-orcid":false,"given":"Jialiang","family":"Wang","sequence":"first","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Liver Disease Research The Third Affiliated Hospital of Sun Yat\u2010Sen University Guangzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunhong","family":"Liao","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Liver Disease Research The Third Affiliated Hospital of Sun Yat\u2010Sen University Guangzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases The Third Affiliated Hospital of Sun Yat\u2010Sen University Guangzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingna","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases The Third Affiliated Hospital of Sun Yat\u2010Sen University Guangzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9189-2619","authenticated-orcid":false,"given":"Lin","family":"Gu","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Liver Disease Research The Third Affiliated Hospital of Sun Yat\u2010Sen University Guangzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9773-4395","authenticated-orcid":false,"given":"Xiaoyan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases The Third Affiliated Hospital of Sun Yat\u2010Sen University Guangzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6451-4022","authenticated-orcid":false,"given":"Lubiao","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases The Third Affiliated Hospital of Sun Yat\u2010Sen University Guangzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,4,22]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32557-1"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-32186-3"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1021\/ja101495v"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14235722"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.12675"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.9b01847"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hbpd.2023.10.009"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1533-0028(11)70509-6"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon.14.108"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13641"},{"issue":"1","key":"e_1_2_11_12_1","first-page":"471","article-title":"Understanding and Improving Platinum Anticancer Drugs: Phenanthriplatin","volume":"34","author":"Johnstone T. C.","year":"2014","journal-title":"Anticancer Research"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.939605"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30207-1"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.6001"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaa038"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111600"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.00608"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13576"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15010109"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrfmmm.2012.12.003"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0708857"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-023-02804-z"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI85647"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.2478\/jtim-2022-0068"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.44.5643"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.00163"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2014-0190"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.09.008"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37542-5"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000430"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA120.013347"},{"issue":"3","key":"e_1_2_11_33_1","first-page":"225","article-title":"A Bibliometric Analysis of Immune\u2010Related Adverse Events in Cancer Patients and a Meta\u2010Analysis of Immune\u2010Related Adverse Events in Patients With Hepatocellular Carcinoma","volume":"12","author":"Wang B.","year":"2024","journal-title":"Journal of Translational Internal Medicine"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.3109\/10409238.2010.502166"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.20892\/j.issn.2095-3941.2020.0550"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2023.102217"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22084098"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1180001"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.32604\/or.2024.047524"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.5847"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1382520"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-22-0769"},{"issue":"8","key":"e_1_2_11_43_1","first-page":"5134","article-title":"PKI\u2010587 Enhances Chemosensitivity of Oxaliplatin in Hepatocellular Carcinoma Through Suppressing DNA Damage Repair Pathway (NHEJ and HR) and PI3K\/AKT\/mTOR Pathway","volume":"11","author":"Zhang Y.","year":"2019","journal-title":"American Journal of Translational Research"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-01938-4"},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-20-1028"},{"key":"e_1_2_11_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.08.020"}],"container-title":["Cell Biology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cbin.70023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T10:53:24Z","timestamp":1750157604000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/cbin.70023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,22]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1002\/cbin.70023"],"URL":"https:\/\/doi.org\/10.1002\/cbin.70023","archive":["Portico"],"relation":{},"ISSN":["1065-6995","1095-8355"],"issn-type":[{"type":"print","value":"1065-6995"},{"type":"electronic","value":"1095-8355"}],"subject":[],"published":{"date-parts":[[2025,4,22]]},"assertion":[{"value":"2025-01-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}